Scarica l'app Stockscreener
5.59
0.18%
-0.010
Precedente Chiudi:
$5.60
Aprire:
$5.56
Volume 24 ore:
1,622
Relative Volume:
0.25
Capitalizzazione di mercato:
$282.22M
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
-2.61%
1M Prestazione:
-6.05%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$5.525
$5.80
Portata 52W:
$5.525
$8.20
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Company Profile
Nome
Clinuvel Pharmaceuticals Limited American Depositary Shares
Settore
Industria
Telefono
-
Indirizzo
-
Compare CUVL vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CUVL
Clinuvel Pharmaceuticals Limited American Depositary Shares
|
5.59 | 282.22M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clinuvel Pharmaceuticals Limited American Depositary Shares Borsa (CUVL) Ultime notizie
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - markets.businessinsider.com
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - GlobeNewswire
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - The Manila Times
Clinuvel Pharmaceuticals (ASX:CUV) Releases FY26 Report After Expanding U.S. Market Access - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV): US Expansion Strategy and Nasdaq Listing Transition - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Makes U.S. Pivot With Nasdaq Uplisting and Headquarters Shift Plan - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Greater US Exposure Trigger a Powerful New Growth Chapter? - Kalkine
Clinuvel Pharmaceuticals (CUVL) uplifts ADR to Level II ADS - Stock Titan
CLINUVEL Pharmaceuticals Completes Nasdaq Uplift with ADS Trading Launch Under CUVL Ticker - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Its New US Listing Transform Global Investor Interest? - Kalkine
CLINUVEL’s ADS to commence trading on Nasdaq - globenewswire.com
CLINUVEL Pharmaceuticals Launches American Depositary Shares on Nasdaq Global Select Market - Kalkine
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
IPO Calendar for: - Yahoo! Finance Canada
CLINUVEL’s ADS to commence trading on Nasdaq - Yahoo Finance
CLINUVEL expects Nasdaq trading; no new shares proposed - Stock Titan
CLINUVEL ADS to commence trading on Nasdaq - scanx.trade
Clinuvel (ASX:CUV) Eyes Nasdaq: What the 20-F Filing Means for CUV Shareholders - Kalkine
CLVLY SEC FilingsClinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Clinuvl Phrmaceu (CLVLY) Stock Price, News & Analysis - Stock Titan
Clinuvel Pharmaceuticals Limited American Depositary Shares Azioni (CUVL) Dati Finanziari
Non sono disponibili dati finanziari per Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.64%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):